Aktien Sensor

Baxter International has launched its revolutionary Hemopatch Sealing Hemostat in Europe, a breakthrough innovation that empowers surgeons to control bleeding and prevent leakage with unprecedented precision.

Baxter International has launched its revolutionary Hemopatch Sealing Hemostat in Europe, a breakthrough product that empowers surgeons to control bleeding and prevent leakage with unprecedented precision.

Baxter International’s stock value has surged, outperforming the healthcare sector, driven by strong Q4 results and the success of its innovative medical device, the Novum IQ pump.

Baxter International Inc exceeded Q4 2024 earnings projections, with shares increasing and management expressing optimism about future prospects.

Baxter has announced a quarterly dividend payment of $0.17 per share, maintaining its commitment to providing a steady income stream for investors.

Baxter has announced a quarterly dividend payment of $0.17 per share, with a dividend yield of 2.22%, to be paid on April 1 to eligible shareholders.

Baxter International’s CEO steps down amidst market volatility, sparking uncertainty about the company’s future trajectory under new leadership.